18F-FDG-PET/CT predicts survival in hypopharyngeal squamous cell carcinoma

被引：19
|
作者：
Suzuki, Hidenori [1 ]
Kato, Katsuhiko [2 ]
Fujimoto, Yasushi [3 ]
Itoh, Yoshiyuki [4 ]
Hiramatsu, Mariko [3 ]
Maruo, Takashi [3 ]
Naganawa, Shinji [4 ]
Hasegawa, Yasuhisa [1 ]
Nakashima, Tsutomu [3 ]
机构：
[1] Aichi Canc Ctr Hosp, Dept Head & Neck Surg, Chikusa Ku, Nagoya, Aichi 4648681, Japan
[2] Nagoya Univ, Sch Hlth Sci, Dept Radiol Technol Hlth Sci, Nagoya, Aichi 4648601, Japan
[3] Nagoya Univ, Dept Otorhinolaryngol, Grad Sch Med, Nagoya, Aichi 4648601, Japan
[4] Nagoya Univ, Dept Radiol, Grad Sch Med, Nagoya, Aichi 4648601, Japan
来源：
ANNALS OF NUCLEAR MEDICINE | 2013年 / 27卷 / 03期
关键词：
F-18-FDG-PET/CT; Hypopharyngeal; Squamous; Cell; Carcinoma; SUVmax; POSITRON-EMISSION-TOMOGRAPHY; PET; GLUT-1; HEAD;
D O I：
10.1007/s12149-013-0686-8
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
We investigated the relationship between overall survival of patients and pretreatment [F-18]-2-fluorodeoxyglucose (F-18-FDG) uptake, assessed by positron emission tomography combined with computed tomography (PET/CT) in hypopharyngeal squamous cell carcinoma. Thirty-one patients who were newly diagnosed as resectable hypopharyngeal squamous cell carcinoma underwent pretreatment F-18-FDG-PET/CT. We used the maximum standardized uptake value (SUVmax) as F-18-FDG uptake. Overall survival rate was calculated by the Kaplan-Meier method. The median SUVmax was 11.53 (range 2.49-22.33). Patients with SUVmax a parts per thousand yen 13 significantly exhibited shorter overall survival in univariate analysis (p < 0.01). Moreover, by Cox proportional hazards model of multivariate analysis, SUVmax a parts per thousand yen 13 was a significant prognostic factor independent of clinical T and N classification, and treatment group (p < 0.02). These results suggested that SUVmax obtained by pretreatment F-18-FDG PET/CT assessment is an important prognostic factor in patients with hypopharyngeal squamous cell carcinoma.
引用
收藏
页码：297 / 302
页数：6
相关论文
共 50 条
  • [1] 18F-FDG-PET/CT predicts survival in hypopharyngeal squamous cell carcinoma
    Hidenori Suzuki
    Katsuhiko Kato
    Yasushi Fujimoto
    Yoshiyuki Itoh
    Mariko Hiramatsu
    Takashi Maruo
    Shinji Naganawa
    Yasuhisa Hasegawa
    Tsutomu Nakashima
    Annals of Nuclear Medicine, 2013, 27 : 297 - 302
  • [2] 18F-FDG-PET/CT can be used to predict distant metastasis in hypopharyngeal squamous cell carcinoma
    Shinsuke Suzuki
    Satoshi Toyoma
    Tomoe Abe
    Tentaro Endo
    Teppei Kouga
    Yohei Kaswasaki
    Takechiyo Yamada
    Journal of Otolaryngology - Head & Neck Surgery, 51
  • [3] 18F-FDG-PET/CT can be used to predict distant metastasis in hypopharyngeal squamous cell carcinoma
    Suzuki, Shinsuke
    Toyoma, Satoshi
    Abe, Tomoe
    Endo, Tentaro
    Kouga, Teppei
    Kaswasaki, Yohei
    Yamada, Takechiyo
    JOURNAL OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2022, 51 (01)
  • [4] ACCURACY OF 18F-FDG-PET/CT FOR STAGING OF ORAL SQUAMOUS CELL CARCINOMA
    Pentenero, Monica
    Cistaro, Angela
    Brusa, Mario
    Ferraris, Maria Maddalena
    Pezzuto, Carla
    Carnino, Riccardo
    Colombini, Edro
    Valentini, Maria Consuelo
    Giovanella, Luca
    Spriano, Giuseppe
    Gandolfo, Sergio
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2008, 30 (11): : 1488 - 1496
  • [5] Accuracy of 18F-FDG-PET/CT in the staging of oral squamous cell carcinoma
    Cistaro, A. S. P. A.
    Pentenero, M.
    Brusa, M.
    Ferraris, M.
    Colombini, E.
    Gandolfo, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 : S255 - S255
  • [6] Clinical value of 18F-FDG-PET/CT in staging cutaneous squamous cell carcinoma
    Mahajan, Sonia
    Barker, Christopher A.
    Singh, Bhuvanesh
    Pandit-Taskar, Neeta
    NUCLEAR MEDICINE COMMUNICATIONS, 2019, 40 (07) : 744 - 751
  • [7] Prognostic Role of Interim 18f-FDG-PET/CT during Chemoradiotherapy in Hypopharyngeal Carcinoma
    Mase, T.
    Toyomasu, Y.
    Watanabe, Y.
    Kawamura, T.
    Takada, A.
    Ochiai, S.
    Yamashita, Y.
    Ii, N.
    Sakuma, H.
    Nomoto, Y.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E366 - E366
  • [8] Evaluation by 18F-FDG-PET of patients with anal squamous cell carcinoma
    Iagaru, Andrei
    Kundu, Rabi
    Jadvar, Hossein
    Nagle, Deborah
    HELLENIC JOURNAL OF NUCLEAR MEDICINE, 2009, 12 (01): : 26 - 29
  • [9] Role of 18F-FDG-PET/CT in Esophageal Squamous Cell Carcinoma After Neoadjuvant Chemoradiotherapy
    Sasaki, Ken
    Uchikado, Yasuto
    Okumura, Hiroshi
    Omoto, Itaru
    Kita, Yoshiaki
    Arigami, Takaaki
    Uenosono, Yoshikazu
    Owaki, Tetsuhiro
    Maemura, Kosei
    Natsugoe, Shoji
    ANTICANCER RESEARCH, 2017, 37 (02) : 859 - 864
  • [10] Comparison of 18F-FDG-PET/MRI and 18F-FDG-PET/CT for initial staging in pulmonary carcinoma
    Luetje, S.
    Ruhlmann, V.
    Bellendorf, A.
    Poeppel, T. D.
    Beiderwellen, K.
    Heusch, P.
    Schaarschmidt, B. M.
    Quick, H. H.
    Nagarajah, J.
    Gomez, B.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S439 - S440
12345